
Degrinta 120mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Degarelix (120mg)
Overview Degrinta 120mg Injection
Provenge (120mg injection) treats advanced prostate cancer by reducing testosterone levels, thereby hindering cancer cell proliferation. Administered subcutaneously by a healthcare professional only, self-injection is strictly prohibited due to the risk of accidental venous injection. Dosage frequency is determined by your physician based on individual needs and treatment goals; continuous use as prescribed is essential. Common side effects may include injection site reactions (pain, swelling, redness), weight gain, hot flushes, elevated liver enzymes, and decreased libido. Report any bothersome or severe side effects to your doctor; management strategies may be available. Avoid operating machinery or driving if experiencing dizziness or sleep disturbances. Prior to treatment, disclose any history of heart disease, diabetes, or liver disease, and list all other medications currently being taken, as interactions may impact effectiveness. Inform your physician if pregnant or breastfeeding. Prostate-specific antigen (PSA) blood tests may monitor treatment efficacy.
Uses of Degrinta 120mg Injection
Malignancy of the prostate gland
Major Benefits of Degrinta 120mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Degrinta 120mg Injection:
- Injection site reactions (pain, swelling, redness)
- Weight gain
- Hot flashes
- Increased liver enzymes
- Low sexual desire
- Erectile dysfunction
How to use Degrinta 120mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Degrinta 120mg Injection works:
Degrinta 120mg Injection reduces endogenous testosterone production. This consequently inhibits or arrests the proliferation of prostate cancer cells reliant on testosterone for growth.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Degrinta 120mg Injection and alcohol. Seek medical advice before doing so.
PregnancyUNSAFE
Administering Degrinta 120mg Injection to pregnant individuals carries substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on Degrinta 120mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The 120mg Degrinta injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 120mg Degrinta injections to individuals with renal impairment. Physician consultation is recommended. Patients exhibiting severe kidney disease should receive Degrinta 120mg Injection with careful consideration.
LiverCAUTION
Administering Degrinta 120mg Injection requires caution in individuals with advanced hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration is typically unnecessary for patients exhibiting mild or moderate liver dysfunction. Routine monitoring of testosterone concentrations is recommended.
What if you forget to take Degrinta 120mg Injection :
Omit a scheduled Degrinta 120mg Injection? Seek your physician's advice.
Facts to Know About Degrinta 120mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Good Habits | No. |
| Type of Therapy | Endocrine Signals |
| Behavioral Class | GnRH receptor blockers |
